Tempus AI’s diagnostic platform drives growth, but US healthcare reimbursement remains a hurdle. Learn why TEM stock is worth watching before buying.

There's nothing quite like the initial shock of thinning hair — an unnerving experience that makes us feel like our confidence is slipping away as fast as our strands. Hair is a big part of one's ...

Researchers at Peter Mac have uncovered potential new heredity genes that might be responsible for causing one of the most prevalent and deadliest forms of ovarian cancer. Their work is published in ...

Intellia Therapeutics NTLA announced that it has dosed the first patient in the phase III HAELO study evaluating NTLA-2002, its novel in vivo CRISPR gene editing therapy for the treatment of ...

The HAELO trial will assess the therapy’s safety and efficacy in 60 adult subjects with Type I or Type II HAE.

Thousands of people in Franklin County, Ohio, now have free access to genetic testing that provides detailed information about their health through a self-administered cheek swab and a genetic ...

Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction.

The swelling started with almost no warning, then seven-year-old Fiona Wardman’s hand ballooned like a rubber glove hooked to ...

Tempus AI claims to have a one-stop-shop, with a flywheel platform that becomes better with each new client. See why I rate ...